Locations:
SearchAdvertisement
Identifying the underlying cause key to successful treatment
Study finds drug safe and effective when combined with chemotherapy
BACE1 inhibitor reduces cancer progression in models of glioblastoma
Multidisciplinary team tackles the management of 84 uncommon cancers and blood disorders
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Specialized clinic addresses long-term wellness through the study of somatic mutations
Common cancer therapy increases serious risks in murine models
Treatment may be a lifesaving option for patients with relapsed or refractory disease
Study suggests new approach is safer than standard treatment and may help prevent graft-versus-host disease
Understudied Src Family Kinase may serve as a potential therapeutic target
Sarcopenia and sarcopenic obesity appear to increase risk of early chemotherapy termination
Advertisement
Advertisement